Charlson weight of comorbidities and comorbidities as independent predictors of in-hospital mortality in patients hospitalised with acute coronary syndrome
| Comorbidities | Charlson weight (points) | OR (95% CI) age and gender—adjusted | p Values |
|---|---|---|---|
| Past history of myocardial infarction | 1 | 0.93 (0.82 to 1.05) | 0.25 |
| Heart failure | 1 | 1.88 (1.57 to 2.25) | <0.001 |
| Peripheral vascular disease | 1 | 1.23 (1.03 to 1.48) | 0.021 |
| Cerebrovascular disease | 1 | 1.26 (1.06 to 1.50) | 0.009 |
| Dementia | 1 | 1.15 (0.90 to 1.47) | 0.27 |
| Chronic lung disease | 1 | 1.18 (0.99 to 1.41) | 0.07 |
| Connective tissue disease | 1 | 0.99 (0.64 to 1.51) | 0.95 |
| Peptic ulcer disease | 1 | 0.98 (0.73 to 1.31) | 0.87 |
| Mild liver disease | 1 | 1.72 (1.09 to 2.70) | 0.019 |
| Diabetes | 1 | 1.35 (1.19 to 1.54) | <0.001 |
| Diabetes with target organ damage | 2 | 1.28 (1.04 to 1.58) | 0.019 |
| Hemiplegia | 2 | 1.92 (1.28 to 5.87) | 0.001 |
| Moderate to severe renal disease | 2 | 1.84 (1.60 to 2.11) | <0.001 |
| Malignant neoplasm | 2 | 1.29 (1.06 to 1.57) | 0.012 |
| Leukaemia | 2 | 1.41 (0.69 to 2.88) | 0.34 |
| Lymphoma | 2 | 0.75 (0.34 to 1.65) | 0.48 |
| Moderate to severe liver disease | 3 | 1.82 (1.12 to 2.95) | 0.016 |
| Metastatic solid tumour | 6 | 2.25 (1.60 to 3.19) | <0.001 |
| AIDS (stage C) | 6 | None of the 47 patients died |